Markets Business Research Reports Exclusives Economy & Finance Law & Policy
Syngene has started producing Remdesivir drug and hopes to start distribution some time in the third quarter. Niraj Shah speaks to the company's MD & CEO Jonathan Hunt to find out more about the drug & Q2.
GET REGULAR UPDATES

RECOMMENDED FOR YOU

CFO Leaders: The Making Of Five Star CFOs 
timelogo Jan 14, 2021
Stocks Rise, Treasuries Fall on Stimulus Bets: Markets Wrap
timelogo Aug 19, 2019
Stocks End Record-Setting Week With Further Gains: Markets Wrap
timelogo Jul 15, 2019
The Mutual Fund Show: The Dos And Don’ts Of Online Investing
timelogo Apr 27, 2019

MUST WATCH VIDEOS

IPO Adda | Indegene Management On IPO Plans | NDTV Profit

IPO Adda | Aadhar Housing Finance MD & CEO Discusses Plans | NDTV Profit

NDTV Profit

IGX MD & CEO Rajesh Mediratta On New Small Scale LNG Contracts | NDTV Profit

NDTV Profit

TBO Tek To Launch Rs 1,550 Crore IPO | NDTV Profit

NDTV Profit

Indeed India's Sashi Kumar On Hiring Trends In India | NDTV Profit

NDTV Profit

Star Health's Q4 Report: Post-Hike Trends Discussed With Nilesh Kambli; Multiple Banking Partnerships

NDTV Profit
View All